Skip to main content
Loading

Enzyme by Design Inc.

October 17, 2023
Franciscan C
Oncology
Enzyme by Design is a preclinical stage biotech startup specializing in engineering highly effective and significantly safer cancer biologics.
Speakers
Amanda Schalk - Drusolv Therapeutics, Inc.

Company Type

Privately Funded

Website

http://www.enzymebydesign.com

CEO/Top Company Official

Arnon Lavie

Lead Product in Development

EBD-300, a novel asparaginase

Number Of Unlicensed Products

3

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS